Dr. Pfister

HOME ::

David A. Pfister, M.D. attended the University of Michigan Medical School in Ann Arbor, Michigan. He completed his Hematology and Oncology fellowship at Memorial Sloan-Memorial Cancer Institute in New York. He is Board Certified in the practice of both Hematology and Oncology. He has devoted his practice to the Oakland, CA area for twenty-one years.

Dr. Pfister is a member of the American Medical Association, American Society of Hematology, and the American Society of Clinical Oncology. He has special interests in integrative and "alternative" medicine including nutritional therapies.

Publications:

		1. Comparison of cisplatin (CDDP) and radiation (RT) to cetuximab (C) and RT for locally advanced head and neck cancer (LAHNC): A preliminary analysis. Meeting: 2009 ASCO Annual Meeting Abstract No: 6042 First Author: L. Koutcher Category: Head and Neck Cancer
		2. Prognostic risk factors to predict final pathohistology in patients undergoing radical salvage prostatectomy for locally recurrent prostate cancer after radiation therapy. Meeting: 2009 Genitourinary Cancers Symposium Abstract No: 142 First Author: A. Heidenreich Category: Genitourinary Cancers - Early/Localized disease, Locally Advanced/Recurrent/Advanced disease, and Biology
		3. Radical cystectomy in the elderly: Functional and oncological outcome. Meeting: 2009 Genitourinary Cancers Symposium Abstract No: 247 First Author: A. Heidenreich Category: Genitourinary Cancers - Bladder
		4. Acupuncture for pain and dysfunction after neck dissection: preliminary results of a randomized controlled trial. Meeting: 2008 ASCO Annual Meeting Abstract No: 6016 First Author: D. Pfister Category: Head and Neck Cancer
		5. Post-chemotherapy retroperitoneal resection of residual masses in germ cell cancer with modified template resection. Meeting: 2008 ASCO Annual Meeting Abstract No: 5089 First Author: A. N. Heidenreich Category: Genitourinary Cancer - Germ Cell / Testicular Tumors
		6. Active surveillance in low-risk prostate cancer: How reliable are preoperative diagnostics? Meeting: 2008 Genitourinary Cancers Symposium Abstract No: 116 First Author: C. H. Ohlmann Category: Genitourinary Cancers - Prostate
		7. Percentage of positive biopsies predicts lymph node involvement in men with low risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy. Meeting: 2008 Genitourinary Cancers Symposium Abstract No: 126 First Author: A. Heidenreich Category: Genitourinary Cancers - Prostate
		8. Post-chemotherapy retroperitoneal resection of residual masses in germ cell cancer with modified template resection. Meeting: 2008 Genitourinary Cancers Symposium Abstract No: 282 First Author: A. Heidenreich Category: Genitourinary Cancers - Testis
		9. Prognostic risk factors to predict final pathohistology in patients undergoing radical salvage prostatectomy for locally recurrent prostate cancer after radiation therapy Meeting: 2008 Genitourinary Cancers Symposium Abstract No: 133 First Author: A. Heidenreich Category: Genitourinary Cancers - Prostate
		10. Surgical management and oncological outcome of renal cell cancer with inferior vena cava thrombus. Meeting: 2008 Genitourinary Cancers Symposium Abstract No: 381 First Author: A. Heidenreich Category: Genitourinary Cancers - Renal